Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q83162666)
Watch
English
Allogeneic hematopoietic cell transplantation versus drugs in myelofibrosis: the risk-benefit balancing act
scientific article published on 01 March 2010
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20216545
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20216545%20AND%20SRC:MED&resulttype=core&format=json
retrieved
19 January 2020
editorial
0 references
review article
1 reference
stated in
Europe PubMed Central
title
Allogeneic hematopoietic cell transplantation versus drugs in myelofibrosis: the risk-benefit balancing act
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20216545
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20216545%20AND%20SRC:MED&resulttype=core&format=json
retrieved
19 January 2020
main subject
myelofibrosis
1 reference
based on heuristic
inferred from title
author name string
A Tefferi
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20216545
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20216545%20AND%20SRC:MED&resulttype=core&format=json
retrieved
19 January 2020
publication date
1 March 2010
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20216545
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20216545%20AND%20SRC:MED&resulttype=core&format=json
retrieved
19 January 2020
published in
Bone Marrow Transplantation
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20216545
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20216545%20AND%20SRC:MED&resulttype=core&format=json
retrieved
19 January 2020
volume
45
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20216545
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20216545%20AND%20SRC:MED&resulttype=core&format=json
retrieved
19 January 2020
issue
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20216545
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20216545%20AND%20SRC:MED&resulttype=core&format=json
retrieved
19 January 2020
page(s)
419-421
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20216545
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20216545%20AND%20SRC:MED&resulttype=core&format=json
retrieved
19 January 2020
exact match
https://scigraph.springernature.com/pub.10.1038/bmt.2009.193
0 references
cites work
New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2009.193
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Red blood cell transfusion need at diagnosis adversely affects survival in primary myelofibrosis-increased serum ferritin or transfusion load does not.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2009.193
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Karyotype complements the International Prognostic Scoring System for primary myelofibrosis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2009.193
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lenalidomide therapy in del(5)(q31)-associated myelofibrosis: cytogenetic and JAK2V617F molecular remissions
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2009.193
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Essential thrombocythemia, polycythemia vera, and myelofibrosis: current management and the prospect of targeted therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2009.193
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2009.193
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2009.193
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2009.193
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
JAK2 inhibitor therapy in myeloproliferative disorders: rationale, preclinical studies and ongoing clinical trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2009.193
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
TG101348, a JAK2-selective antagonist, inhibits primary hematopoietic cells derived from myeloproliferative disorder patients with JAK2V617F, MPLW515K or JAK2 exon 12 mutations as well as mutation negative patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2009.193
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2009.193
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2009.193
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Monitoring of the JAK2-V617F mutation by highly sensitive quantitative real-time PCR after allogeneic stem cell transplantation in patients with myelofibrosis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2009.193
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Survival in young patients with intermediate- / high-risk myelofibrosis: estimates derived from databases for non transplant patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2009.193
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Allogeneic hemopoietic SCT for patients with primary myelofibrosis: a predictive transplant score based on transfusion requirement, spleen size and donor type
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2009.193
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Conventional cytogenetics in myelofibrosis: literature review and discussion
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2009.193
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2009.193
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1038/BMT.2009.193
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20216545
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20216545%20AND%20SRC:MED&resulttype=core&format=json
retrieved
19 January 2020
Dimensions Publication ID
1046625549
0 references
PubMed publication ID
20216545
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20216545
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20216545%20AND%20SRC:MED&resulttype=core&format=json
retrieved
19 January 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
